Source: Journal of Glaucoma. Unidade: FMRP
Subjects: HIPERTENSÃO OCULAR (QUIMIOTERAPIA;PREVENÇÃO E CONTROLE), FÁRMACOS (ANÁLISE), ANTICORPOS MONOCLONAIS (ADMINISTRAÇÃO E DOSAGEM)
ABNT
KATAYAMA, Bianka Y. N. Y. et al. Comparison of acetazolamide, brimonidine, and anterior chamber paracentesis for ocular hypertension control after initial intravitreal bevacizumab injection: a randomized clinical trial. Journal of Glaucoma, v. 23, n. 7, p. 461-463, 2014Tradução . . Disponível em: https://doi.org/10.1097/IJG.0b013e3182948476. Acesso em: 09 maio 2024.APA
Katayama, B. Y. N. Y., Bonini Filho, M. A., Messias, A. M. V., Paula, J. S. de, Martins, L. F. T., Costa, R., & Jorge, R. (2014). Comparison of acetazolamide, brimonidine, and anterior chamber paracentesis for ocular hypertension control after initial intravitreal bevacizumab injection: a randomized clinical trial. Journal of Glaucoma, 23( 7), 461-463. doi:10.1097/IJG.0b013e3182948476NLM
Katayama BYNY, Bonini Filho MA, Messias AMV, Paula JS de, Martins LFT, Costa R, Jorge R. Comparison of acetazolamide, brimonidine, and anterior chamber paracentesis for ocular hypertension control after initial intravitreal bevacizumab injection: a randomized clinical trial [Internet]. Journal of Glaucoma. 2014 ; 23( 7): 461-463.[citado 2024 maio 09 ] Available from: https://doi.org/10.1097/IJG.0b013e3182948476Vancouver
Katayama BYNY, Bonini Filho MA, Messias AMV, Paula JS de, Martins LFT, Costa R, Jorge R. Comparison of acetazolamide, brimonidine, and anterior chamber paracentesis for ocular hypertension control after initial intravitreal bevacizumab injection: a randomized clinical trial [Internet]. Journal of Glaucoma. 2014 ; 23( 7): 461-463.[citado 2024 maio 09 ] Available from: https://doi.org/10.1097/IJG.0b013e3182948476